READING CHRISTOPHER J 4
4 · U S PHYSICAL THERAPY INC /NV · Filed Aug 19, 2019
Insider Transaction Report
Form 4
READING CHRISTOPHER J
DirectorChairman of the Board and CEO
Transactions
- Sale
Common Stock
2019-08-16$135.07/sh−1,500$202,605→ 66,957 total - Sale
Common Stock
2019-08-15$135.39/sh−601$81,369→ 68,457 total - Sale
Common Stock
2019-08-19$135.12/sh−4,899$661,953→ 62,058 total
Footnotes (4)
- [F1]The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $135.06 to $136.22 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc. any of its shareholders or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- [F2]Includes 39,525 shares which restrictions lapse as to 4,984 shares on each of October 1, 2019 and January 1, 2020; 3,564 shares on each of April 1, July 1 and October 1, 2020; 3,578 shares on January 1, 2021; 2,543 shares on each of April 1, July 1 and October 1, 2021 and on January 1, 2022; 1,278 on each of April 1, July 1 and October 1, 2022; and 1,281 on January 1, 2023
- [F3]The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $135.00 to $135.31 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc. any of its shareholders or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- [F4]The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $134.77 to $135.51 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc. any of its shareholders or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.